This opportunity funds clinical research programs by comprehensive cancer infrastructures targeting lung, bowel, breast, or prostate cancer. Projects should focus on innovative diagnostics, therapies including radiotherapy, surgery, chemotherapy, and therapeutic cancer vaccines, and implementation of clinical guidelines. Funded activities include piloting and upscaling programs in multiple EU Member States and Associated Countries, especially in regions with less developed cancer infrastructures, to improve diagnosis and treatment accessibility and effectiveness.
Eligible applicants must comply with Horizon Europe general conditions including admissibility, eligible countries, financial and operational capacity, and other criteria detailed in the Work Programme General Annexes. Proposals must follow specified page limits and layouts and meet evaluation thres
